1. Home
  2. NNY vs MIST Comparison

NNY vs MIST Comparison

Compare NNY & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New York Municipal Value Fund

NNY

Nuveen New York Municipal Value Fund

HOLD

Current Price

$8.66

Market Cap

161.7M

Sector

Finance

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$1.65

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNY
MIST
Founded
1987
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.7M
176.3M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
NNY
MIST
Price
$8.66
$1.65
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
43.1K
1.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.04%
N/A
EPS Growth
N/A
51.80
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.77
$0.63
52 Week High
$8.94
$3.06

Technical Indicators

Market Signals
Indicator
NNY
MIST
Relative Strength Index (RSI) 53.88 35.30
Support Level $8.30 $1.62
Resistance Level $8.83 $1.79
Average True Range (ATR) 0.15 0.07
MACD 0.01 0.01
Stochastic Oscillator 55.26 17.39

Price Performance

Historical Comparison
NNY
MIST

About NNY Nuveen New York Municipal Value Fund

Nuveen New York Municipal Value Fund Inc. is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: